Dr. Barish joined the faculty in 2018 as Clinical Assistant Professor of Medicine in the Division of Gastroenterology and Hepatology after retiring from 33 years of practicing gastroenterology in Raleigh, NC. He is currently mentoring our GI fellows in their clinics and believes that there are two secrets to success as a physician: listening to patients and staying current with advances in medicine.
As a practicing gastroenterologist, he treated most GI disorders but had a particular interest in the diagnosis and management of inflammatory bowel disease. He has been active in clinical research since 1985 and has authored and co-authored numerous articles regarding GI diseases in various medical journals and books.
Dr. Barish is listed as a Top Doctor with US News and World Report, Castle Connolly, Becker’s GI & Endoscopy, Guide to Americas Top Physicians and American Registry’s Top 5% of “Most Honored Professionals”. He was also one of the first physicians recognized in the Bridges to Excellence IBD Care Recognition Program, sponsored by the American Gastroenterological Association’s Health Care Incentives Improvement Institute.
- Gastroenterol. 2018: 154(6):S-499. DOI: 10.1016/S0016-5085(18)31892-4. Safety, Tolerability, and Effectiveness of Plecanatide in Patients with Constipation-Predominant Irritable Bowel Syndrome: Long-Term Evidence from an Open-Label Study.
- CMRO. 2018: 34(2):1-14. DOI: 10.1080/03007995.2018.1430024. Safety and Tolerability of Plecanatide in Patients with Chronic Idiopathic Constipation: Long-Term Evidence from an Open-Label Study.
- Anemia. 2012(5):172104. DOI: 10.1155/2012/172104. Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials.
- Dig Dis Sci. 2010: 55(4): 1090-7. DOI: 10.1007/s10620-009-1068-x. Epub 2009 Dec 11. Efficacy and Safety of Lubiprostone in Patients with Chronic Constipation.
- Am J Gastroenterol. 2009: 104 (3): S361. Use of Adalimumab in Crohn’s Related Cavitary and Granulomatous Lung Disease.
- Expert Opin Biol Ther. 2005: 5:10, 1387-91. DOI: 0.1517/14712522.214.171.1247. Alicaforsen Therapy in Inflammatory Bowel Disease.
Education and Training
|BS||University of Florida||Chemistry|
|MD||University of Florida||Medicine|
|Residency||Wake Forest School of Medicine||Internal Medicine|
|Fellowship||Wake Forest School of Medicine||Gastroenterology|